No description available.

Although the molecular mechanisms underlying the onset and progression of cancer has been unraveled to a great extend, cancer continues to remain a leading cause of death around the world. Clinical efficacy of the existing anticancer drugs are largely compromised by the inherent and acquired resistance of cancer cell types and the severe side effects evoked by chemotherapeutic agents. Hence, the search for novel anticancer drugs with minimum side effects remains an active area of cancer research. Although molecular targeted drugs are preferred over the conventional cytotoxic chemotherapy, the screening of natural compounds with cytotoxic potentialities continues as they can serve as lead structures for the development of tumor selective anticancer drugs. Plants and microorganisms have been the prominent sources of therapeutic agents. Microorganisms being readily renewable, inexhaustible sources of diverse bioactive secondary metabolites are preferred over plants as sources of bioactive compounds. Endophytes are microorganisms that reside within the living tissue of host plant and they enhance the survival value of the host plant by mediating various stress tolerance mechanisms. Endophytic fungi have gained attention as potential sources of bioactive secondary metabolites following the discovery of a taxol producing endophytic fungus Taxomyces adrenae, from Taxus brevifolia. Moreover, endophytes occupy a unique biological niche in which they maintain a balanced interaction with the host organism and other co-inhabiting microorganisms. All these factors contribute to the chemical diversity of the metabolites they produce. Plants restricted to extreme or unique habitats or those with ethnobotanical value are likely to lodge endophytes that possess a unique hoard of secondarymetabolites. Saraca asoca is a traditionalmedicinal plant with its occurrence restricted to countries such as India, Sri Lanka, Burma and Malaysia. The purpose of the present study is to explore the endophytic fungal population associated with S. asoca in search of novel anticancer lead structures. S. asoca was found to house a diverse endophytic fungal population belonging to 37 different species. Identification of the fungal isolates was based on ITS (internal transcribed spacer region) sequence analysis as well as colony and spore characteristics. The organic extracts of all fungal species were assessed for their in vitro cytotoxicities in three human cancer cell lines, HeLa, HepG2 and PC3 byMTT assay. 18 species exhibited remarkable cytotoxic activities, among which Pestalotiopsis sp. 6 exhibited themost significant cytotoxicity. The strain with second highest activity was Lasiodiplodia theobromae. In order to identify the active principle present in the organic extracts of Pestalotiopsis sp. 6 and L. theobromae, the organic extracts were chromatographed on TLC plates and individual compounds were recovered by scraping off from the TLC plates and extracting with methanol. The cytotoxicity assay of the TLC purified compounds suggested the cytotoxic activity of Pestalotiopsis sp.6 to be a synergetic effect of two or more compounds whereas the cytotoxicity of L. theobromae organic extract was largely due to a single compound. Hence the active principle present in L. theobromae organic extract was purified by bioassay - guided column chromatography. Repeated chromatography of the crude extract using three silica gel columns resulted in the isolation of anticancer compound. Based on the analysis of ESI-MS, IR, NMR and UV spectral data, the isolated compound was identified as a novel steroidal saponin, cholestan-3-O-¯-Dglucopyranoside (cholestanol glucoside - CG). The in vitro cytotoxic effects of CG towards seven human cancer cell lines, HeLa, HepG2, PC3, U251,MCF 7, OVCAR3 and A549 were examined. Among the cell lines screened, HeLa cells weremost vulnerable to CG treatment, with an IC50 value of 3.2 ¹M. Hence themode of cell death induction in HeLa cells by CG was further investigated. Analysis of cell cycle progression by propidium iodide (PI) staining revealed that CG arrests the cells in S phase of cell cycle prior to the induction of cell death. The morphological and biochemical features of apoptosis were investigated by nuclear staining, DNA fragmentation assay and Annexin V-FITC/ PI dual staining. All these results suggested that CG effectively induced apoptosis in HeLa cells in a concentration dependent manner. It was also found that CG treatment induced remarkable ROS generation and mitochondrial membrane potential loss. The pretreatment of cells with an antioxidant, N-acetyl cysteine (NAC), blocked CG induced ROS generation, mitochondrialmembrane depolarization and apoptotic cell death. Hence it could be concluded that CG kills the cancer cells by augmenting their basal oxidative stress and hence is less likely to be toxic to normal cells. Moreover, a high Bax to Bcl-2 ratio, high levels of Apaf-1 and p53, activation of procaspase-3 and procaspase-9 and cleavage of PARP were observed in CG treated HeLa cells. Taken together, our results suggested that CG induced apoptosis in HeLa cells via ROS mediated mitochondria dependent pathway. Biosynthesis of secondarymetabolites by filamentous fungi is influenced by the availability of nutrient factors. Therefore, it is essential to optimize the culturemedium components to ensure a maximum and consistent yield of desired metabolite by the fungal isolate. We designed a chemically defined production medium for CG production by L. theobromae. Carbon source, nitrogen source and microelements in the production medium were further optimized in stationary flask cultures to improve the mycelial growth and yield of CG by L. theobromae. The conventional one-factor at a time (OFAT)method was employed for the optimization of carbon and nitrogen sourceswhose contribution effects towards the final yield are large. Response surface methodology (RSM) was employed for the optimization of microelements. Optimization of culturemedium enhanced the yield of CG from 10mg L¡1 to 50mg L¡1. Various secondarymetabolites are produced by organisms in response to different stress conditions. This knowledge has been exploited in plant cell culture systems to increase the yield of particular secondary metabolites by artificial implementation of stress conditions. We investigated the effect of oxidative, osmotic and heat shock stresses on the production of CG by L. theobromae. Heat shock and osmotic stresses in liquid cultures were found to enhance the yield of CG by 1.2-fold, relative to the controls. Oxidative stress by both menadione and H2O2 enhanced the yield by 1.8-fold compared to the controls. Thus oxidative stress proved to be an efficient enhancer of CG production by L. theobromae. These findings ensure a large scale, cost-effective production of CG.

Resumé<p><p>Le cancer reste une maladie grave car il représente une des causes principales de décès dans les pays développés. Plus d'un tiers de cancers solides réagi très faiblement à la chimiothérapie conventionnelle et/ou développe rapidement une résistance au traitement. Des thérapies ciblées, utilisées en association avec les traitements conventionnels, pourraient augmenter la survie des patients. C’est dans le cadre des thérapies ciblées que ce travail de thèse s’inscrit.<p><p>Nous nous sommes intéressés à synthétiser de nouvelles molécules qui pourraient être efficaces contre les cancers résistants à l'apoptose et donc aux traitements conventionnels. La principale cible de notre projet était la kinase DYRK1A, qui a été décrite comme étant impliquée dans la prolifération cellulaire et la résistance à l'apoptose. Dans ce but, une série de nouvelles molécules, principalement des dérivés de la tétrahydro-β-carboline, a été synthétisée et leurs propriétés antitumorales ont été caractérisées in vitro. En effet, ces structures ressemblent à celle de l’harmicine, un alcaloïde apparenté à l’harmine, l’inhibiteur de DYRK1A le plus sélectif et le plus puissant connu à ce jour. <p><p> Une méthodologie "one-pot" très efficace, développée au Laboratoire de Chimie Organique (ULB), a été utilisée pour obtenir les squelettes de type tétrahydro-β-carboline. Le deuxième chapitre de cette thèse détaille cette méthodologie et décrit la librairie de 47 dérivés qui ont été synthétisés. <p><p>Un second objectif de ce travail était de développer une version énantiosélective de cette méthodologie afin de la rendre encore plus intéressante. Cette partie, décrite dans le troisième chapitre, a été réalisée avec succès en collaboration avec l’Unité de Recherche en Chimie Organique et Macromoléculaire de l'Université du Havre (Le Havre, France). Les expériences que nous avons réalisées ont permis, non seulement d'obtenir le composé le plus actif avec un bon excès énantiomérique, mais également de mieux comprendre les aspects mécanistiques qui constituent la base de l'énantiosélectivité. <p><p>L'évaluation des propriétés anticancereuses des composés synthétisés est ensuite détaillée dans le quatrième chapitre. Les analyses toxicologiques et pharmacologiques ont montré que trois molécules présentent une bonne activité antitumorale in vitro avec une sélectivité prometteuse entre les cellules cancéreuses et les cellules normales. D’une manière inattendue, les tests biologiques plus poussés, que nous avons réalisés, ont suggéré que ces molécules n'agissent pas comme des inhibiteurs de kinases. Elles interfèrent en fait sur la prolifération cellulaire, en ciblant des facteurs de transcription spécifiques, par des mécanismes qui doivent encore être élucidés. Ces expériences biologiques ont été réalisées en collaboration avec le Laboratoire de Toxicologie et Cancérologie Expérimentale (ULB).<p><p>/<p><p>Summary<p><p>Cancer is a devastating disease which remains one of the major causes of death in developed countries. More than one third of adult solid cancers respond very poorly to chemotherapy and/or rapidly develop resistance to treatment. Targeted therapies, used in combination with conventional treatments could be used to increase the survival of cancer patients.<p><p>In this work we were interested in developing new molecules related to the targeted therapy concept that could be effective against cancer types that are resistant to apoptosis and thereby to conventional treatments. The leading target of our project was the DYRK1A kinase, which was described as being involved in cell proliferation and resistance to apoptosis. For this purpose, a series of new molecules, mainly tetrahydro β carboline derivatives, has been synthesized and their antitumoral properties were characterized in vitro. Indeed these structures resemble harmicine, an alkaloid similar to harmine, the most selective and potent DYRK1A inhibitor known to date.<p><p> An efficient “one-pot” methodology, developed in the Laboratoire de Chimie Organique (ULB) was used to obtain the tetrahydro β carboline scaffolds. Chapter II of this work describes the use of this methodology for the synthesis of a library of 47 derivatives.<p><p>A second goal of this work was to further improve this methodology by developing an enantioselective version. This part, described in chapter III, was carried out successfully in collaboration with the Research Unit in Macromolecular and Organic Chemistry of Université du Havre (Le Havre, France). The experiments we have performed enabled us not only to obtain the most active compound with a good enantiomeric excess, but also to gain insight of the mechanism responsible for the enantioselectivity.<p><p>The fourth chapter details the evaluation of the anti cancer properties of the synthesised compounds. The pharmacological and toxicological analyses showed that 3 molecules display actual anti-tumor activity in vitro with a promising selectivity between cancerous and normal cells. Surprisingly, further biological assays we have performed suggested that these molecules do not act as kinase inhibitors but influence cell proliferation through the targeting of specific transcription factors by mechanisms that remain to be deciphered. The biological experiments were performed in collaboration with the Cancerology and Experimental Toxicology Laboratory (ULB).<p><p><p><p><p><p> / Doctorat en Sciences / info:eu-repo/semantics/nonPublished